Stephen Saad’s stake in Africa’s largest pharmaceutical company sinks below $600 million
South African pharmaceutical tycoon Stephen Saad faces setback as Aspen Pharmacare shares decline.
Related
Stephen Saad raises Aspen stake by $5.6 million amid stock slump
Stephen Saad invests $5.6 million more in Aspen amid its biggest stock slump in two decades, signaling confidence in the company’s long-term outlook.
Stephen Saad loses $130 million as Aspen shares fall amid contract dispute
This follows a $148.7 million contract dispute tied to mRNA technology.
Stephen Saad’s Aspen faces $148.7 million contract dispute
Aspen shares dive 30% amid $148.7 million mRNA tech dispute, stoking investor fears over financial stability.
Stephen Saad’s stake in Aspen slips below $450 million
South African pharma tycoon Stephen Saad’s stake in Aspen Pharmacare drops to $434.35 million, losing $62.85 million in 15 days.
Latest
Anthony Joshua falls off 2025 Forbes list of highest-paid athletes
British-Nigerian boxing star Anthony Joshua falls off Forbes 2025 list of highest-paid athletes following earnings decline and costly defeat.
Fawry delivers Q1 revenue of $53.3 million under Ashraf Sabry
Fawry’s Q1 2025 revenue surged 65.1% to $53.3 million under Ashraf Sabry, with record digital transactions and profit, cementing its fintech dominance in Egypt.
Co-op Bank delivers Q1 profit of $53.3 million under Gideon Muriuki
Co-op Bank posted a $53.3 million Q1 profit, up 5.3%, driven by digital lending, strong interest income, and operational efficiency under CEO Gideon Muriuki.
Adrian Gore makes move in renewable energy for African SMEs
This marks the first time wheeled electricity, energy generated from remote wind and solar farms and delivered via the grid, has been made accessible to businesses of all sizes.